Indefinite Delivery Contract SPM20005D1021

This indefinite delivery contract (IDC) was awarded by the U.S. Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $500 million single-award IDC, with a period of performance from January 2005 through March 2015, serves as the primary vehicle for Amerisourcebergen to deliver specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities across multiple therapeutic areas. The contract did not include any set-aside requirements, indicating open competition. The DLA Troop Support Medical, responsible for the Medical Supply Chain, is the primary agency utilizing this IDC through numerous firm-fixed-price delivery orders for supplies delivered to Chesterbrook, Pennsylvania. These delivery orders, valued up to $59,255.86, cover a wide variety of pharmaceutical and medical products needed to support TRICARE North military healthcare operations.

In addition to the DLA IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable the U.S. government to efficiently procure essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism with a leading pharmaceutical distribution company.